SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 1, 2000
INAMED CORPORATION
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 59-0929629
(State of Incorporation or Organization) (IRS Employer Identification No.)
001-09741
(Commission File Number)
5540 Ekwill Street - Suite D, Santa Barbara, California 93111-2919
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events.
On February 1, 2000, the Registrant announced results for the fourth
quarter of fiscal year 1999. The Registrant's press release dated February 1,
2000 containing further detail is attached.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) Not applicable
(b) Not applicable
(c) Exhibits:
The following exhibits are filed herewith:
Exhibit Description
99.1 Press Release dated February 1, 2000.
99.2 Schedule II, Valuation and Qualifying Accounts to Audited Consolidated
Financial Statements of Collagen Aesthetics, Inc., as filed as Annex A
to Form 8-K/A on November 9, 1999.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INAMED CORPORATION
By: /s/ David E. Bamberger
-----------------------------------
Name: David E. Bamberger
Title: Sr. Vice President
Date: February 4, 2000
EXHIBIT INDEX
99.1 Press Release dated February 1, 2000.
99.2 Schedule II, Valuation and Qualifying Accounts to Audited Consolidated
Financial Statements of Collagen Aesthetics, Inc., as filed as Annex A
to Form 8-K/A on November 9, 1999.